Monte Rosa Therapeutics recently reported updated Phase 1/2 data showing that its investigational GSPT1 degrader MRT-2359, in combination with enzalutamide, was well-tolerated and produced positive ...

New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...

Bayer (XTRA:BAYN) has received preliminary US court approval for a multibillion-dollar class action settlement tied to Monsanto's Roundup weedkiller. The proposed agreement is intended to address tens ...

Bayer has reported a major development within its pharmaceutical pipeline, with new clinical trial data indicating a significant improvement in survival rates for patients with advanced prostate ...

Novartis said on Wednesday it intends to build a radioligand therapy manufacturing site in Texas, expanding its U.S. footprint with what will be its first such facility in the state ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...

In the real-world, Pluvicto showed 13.5 months median PFS in chemo-naïve patients with PSMA-positive mCRPCReal-world evidence showed Pluvicto achieved longer PFS when initiated after one ARPI instead ...

Investing.com - Bayer AG filed a lawsuit Monday in New York federal court accusing Johnson & Johnson of making false and misleading claims in advertisements for its prostate cancer drug Erleada, ...

In A Nutshell About one in ten cancer patients developed a new mental health disorder, most often anxiety or depression, within a year of their diagnosis. Those patients were 51% more likely to die ...

Bayer sued Johnson & Johnson on Monday, accusing the rival drugmaker of falsely advertising a drug intended to treat prostate cancer.

Thirty-eight years ago, I was initiated into the oldest and one of the largest Black fraternities in the world: Alpha Phi Alpha Fraternity, Inc. It was one of the happiest days of my life. In ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...